Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 14 studies | 37% ± 11% | |
| glutamatergic neuron | 10 studies | 45% ± 23% | |
| GABAergic neuron | 8 studies | 46% ± 20% | |
| neuron | 7 studies | 28% ± 14% | |
| retina horizontal cell | 6 studies | 33% ± 9% | |
| astrocyte | 6 studies | 30% ± 12% | |
| amacrine cell | 5 studies | 25% ± 2% | |
| interneuron | 5 studies | 50% ± 19% | |
| retinal cone cell | 5 studies | 20% ± 2% | |
| retinal bipolar neuron | 4 studies | 20% ± 4% | |
| microglial cell | 4 studies | 23% ± 4% | |
| oligodendrocyte precursor cell | 4 studies | 23% ± 5% | |
| GABAergic interneuron | 3 studies | 32% ± 5% | |
| granule cell | 3 studies | 29% ± 11% | |
| mast cell | 3 studies | 25% ± 11% | |
| ciliated cell | 3 studies | 22% ± 4% | |
| macrophage | 3 studies | 17% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 15 studies | 34% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 4336.69 | 2618 / 2642 | 100% | 11.02 | 704 / 705 |
| adrenal gland | 90% | 1103.19 | 233 / 258 | 93% | 14.22 | 214 / 230 |
| ovary | 90% | 1640.72 | 162 / 180 | 54% | 1.34 | 234 / 430 |
| breast | 39% | 467.13 | 181 / 459 | 77% | 6.40 | 857 / 1118 |
| lung | 51% | 426.59 | 295 / 578 | 31% | 0.92 | 362 / 1155 |
| spleen | 66% | 413.37 | 159 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 15% | 88.98 | 50 / 328 | 35% | 1.26 | 62 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 0.87 | 13 / 29 |
| intestine | 13% | 80.37 | 123 / 966 | 29% | 0.64 | 154 / 527 |
| stomach | 7% | 44.58 | 25 / 359 | 29% | 0.58 | 83 / 286 |
| uterus | 4% | 42.46 | 6 / 170 | 22% | 0.66 | 100 / 459 |
| kidney | 17% | 165.74 | 15 / 89 | 4% | 0.10 | 40 / 901 |
| esophagus | 1% | 4.21 | 10 / 1445 | 20% | 0.48 | 36 / 183 |
| skin | 8% | 52.14 | 148 / 1809 | 10% | 0.23 | 45 / 472 |
| bladder | 0% | 0 | 0 / 21 | 13% | 0.43 | 65 / 504 |
| peripheral blood | 12% | 79.86 | 110 / 929 | 0% | 0 | 0 / 0 |
| prostate | 9% | 54.92 | 21 / 245 | 3% | 0.04 | 13 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.08 | 3 / 45 |
| thymus | 1% | 6.78 | 7 / 653 | 3% | 0.07 | 19 / 605 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
| adipose | 2% | 17.90 | 30 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 2% | 12.20 | 23 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.02 | 5 / 406 |
| heart | 0% | 0.49 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042391 | Biological process | regulation of membrane potential |
| GO_0050804 | Biological process | modulation of chemical synaptic transmission |
| GO_2000302 | Biological process | positive regulation of synaptic vesicle exocytosis |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0150104 | Biological process | transport across blood-brain barrier |
| GO_1902476 | Biological process | chloride transmembrane transport |
| GO_0110010 | Biological process | basolateral protein secretion |
| GO_0051453 | Biological process | regulation of intracellular pH |
| GO_0015701 | Biological process | bicarbonate transport |
| GO_0035725 | Biological process | sodium ion transmembrane transport |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098793 | Cellular component | presynapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0043195 | Cellular component | terminal bouton |
| GO_0030672 | Cellular component | synaptic vesicle membrane |
| GO_0043679 | Cellular component | axon terminus |
| GO_0032809 | Cellular component | neuronal cell body membrane |
| GO_0043005 | Cellular component | neuron projection |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0030425 | Cellular component | dendrite |
| GO_0032279 | Cellular component | asymmetric synapse |
| GO_0097457 | Cellular component | hippocampal mossy fiber |
| GO_0008021 | Cellular component | synaptic vesicle |
| GO_0032280 | Cellular component | symmetric synapse |
| GO_0097386 | Cellular component | glial cell projection |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0015081 | Molecular function | sodium ion transmembrane transporter activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0140892 | Molecular function | sodium,bicarbonate:chloride antiporter activity |
| GO_0015106 | Molecular function | bicarbonate transmembrane transporter activity |
| GO_0015108 | Molecular function | chloride transmembrane transporter activity |
| GO_0005452 | Molecular function | solute:inorganic anion antiporter activity |
| GO_0008510 | Molecular function | sodium:bicarbonate symporter activity |
| Gene name | SLC4A8 |
| Protein name | Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3) |
| Synonyms | KIAA0739 NBC3 NBC NDCBE1 |
| Description | FUNCTION: Mediates electroneutral sodium- and carbonate-dependent chloride-HCO3(-) exchange with a Na(+):HCO3(-) stoichiometry of 2:1 . Plays a major role in pH regulation in neurons (By similarity). Mediates sodium reabsorption in the renal cortical collecting ducts (By similarity). . |
| Accessions | Q2Y0W8 ENST00000358657.7 [Q2Y0W8-5] ENST00000514353.7 [Q2Y0W8-7] ENST00000535225.6 [Q2Y0W8-8] ENST00000453097.7 [Q2Y0W8-1] |